GCG and hyperinsulinemic hypoglycemia, familial, 4: The other strategies targeting the associated physiopathological mechanisms such as Lactobacillus-based probiotics, N-acetylcysteine, nuclear receptor agonists (Pioglitazone), GLP-1 agonists (Liraglutide), DDP-4 inhibitors (Sitagliptin), omega-3 fatty acids (docosahexaenoic acid) or bile acids (obeticholic acid) and vitamin E, with/without vitamin D in cases of deficiency remain under research (40, 44, 45, 129–132).